key: cord-0877261-0cv7r3ow
authors: Harrogate, Suzanne; Mortimer, Alex; Burrows, Lorna; Fiddes, Barnaby; Thomas, Ian; Rice, Claire M.
title: Non-aneurysmal subarachnoid haemorrhage in COVID-19—authors’ reply to Kawada T
date: 2021-04-17
journal: Neuroradiology
DOI: 10.1007/s00234-021-02712-z
sha: 46118ec1a87e44e23f50bd95b26495886149c8ba
doc_id: 877261
cord_uid: 0cv7r3ow

nan

We are grateful to Dr. Kawada for highlighting additional cases of non-aneurysmal subarachnoid haemorrhage (SAH) which have occurred in the context of severe coronavirus disease 2019 (COVID-19). Indeed, several additional case series have recently been published, including those with pathological findings [1] [2] [3] , and we anticipate that additional cases of CNS haemorrhagic complications of COVID-19 infection will be reported in emerging registry data.

Although we wish to raise awareness of the risk of SAH in COVID-19, we consider that, for the majority of patients, thrombosis is likely to present a greater risk [4] . However, while early use of prophylactic anticoagulation was associated with lower mortality without an increase in morbidity in a large observational study [5] , recruitment to clinical trials of therapeutic anticoagulation in those requiring intensive care unit support has been halted [6] . It remains to be determined, whether immunomodulatory treatment alters the risk of thrombosis and haemorrhage in patients with severe COVID-19 [7] .

Until best practice is determined definitively and predication of individual risk improved, we strongly recommend that centres follow credible guidelines such as those issued by the National Institute for Health and Care Excellence (NICE) [8] , the International Society on Haemostasis and Thrombosis [9] and the American Society of Hematology [10] , with standardised reporting of both thrombotic and haemorrhagic events occurring in the context of COVID-19 infection.

The authors declare that they have no conflict of interest.

Informed consent No human participants.

Neuroimaging findings in conjunction with severe COVID-19

Neuropathologic findings of patients with COVID-19: a systematic review

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

Zarychanski R (2021) Therapeutic anticoagulation in critically ill patients with COVID-19 -preliminary report

Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxis

National Institute for Health and Clinical Care (NICE; NG191) (2021) COVID-19 rapid guideline: managing COVID-19

Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19

of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19